Lymphokine‐activated killer (LAK) activity to cultured rat kidney parenchymal components in vitro

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Transplant International

• Publication date

  1989-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1432-2277.1989.tb01868.xPMID 2627263
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cells mediating allograft rejection.

  1991cited by this paper
• Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells.

  1989cited by this paper
• Antigen expression in different parenchymal cell types of rat kidney and heart.

  1989cited by this paper
• Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity.

  1988cited by this paper
• Increased resistance to non-MHC-restricted cytotoxicity related to HLA A, B expression. Direct demonstration using beta 2-microglobulin-transfected Daudi cells.

  1988cited by this paper
• Accessory cells, dendritic cells, or monocytes, are required for the lymphokine-activated killer cell induction from resting T cell but not from natural killer cell precursors.

  1988cited by this paper
• Interferon‐gamma protects human endothelial cells from lymphokine‐activated killer cell‐mediated lysis

  1988cited by this paper
• Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells

  1988cited by this paper
• Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.

  1988cited by this paper
• Frequency and Functional Characterization of Specific T‐Helper Cells Infiltrating Rat Kidney Allografts during Acute Rejection

  1987cited by this paper
• Precursor phenotype of lymphokine-activated killer cells in the mouse.

  1987cited by this paper
• EVIDENCE THAT THYMECTOMIZED, BONE MARROW‐RECONSTITUTED RATS DO NOT REJECT THEIR ALLOGRAFTS

  1987cited by this paper
• Endothelial cell lysis induced by lymphokine‐activated human peripheral blood mononuclear cells

  1987cited by this paper
• In vivo mechanisms of alloreactivity. I. Frequency of donor-reactive cytotoxic T lymphocytes in sponge matrix allografts.

  1986cited by this paper
• Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.

  1986cited by this paper
• Monocyte‐dependent induction of proliferation of human peripheral T cells by recombinant interleukin 2

  1986cited by this paper
• Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis

  1986cited by this paper
• Destruction of autologous human lymphocytes by interleukin 2-activated cytotoxic cells.

  1986cited by this paper
• Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells.

  1985cited by this paper
• Lack of evidence for an active role for natural killer cells in acute rejection of organ allografts.

  1985cited by this paper
• Mechanisms of Rejection and Prolongation of Vascularized Organ Allografts

  1984cited by this paper
• In situ effector pathways of allograft destruction. 1. Generation of the "cellular" effector response in the graft and the graft recipient.

  1984cited by this paper
• Mechanisms of Allograft Rejection: The Roles of Cytotoxic T‐Cells and Delayed‐Type Hypersensitivity

  1984cited by this paper
• Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts.

  1984cited by this paper
• Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells

  1983cited by this paper
• Immune mechanisms in organ allograft rejection. II. T helper cells, delayed-type hypersensitivity, and rejection of renal allografts.

  1983cited by this paper
• Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines.

  1983cited by this paper
• Lymphoid cell subclasses in rejecting renal allograft in the rat.

  1983cited by this paper
• Are “natural killer” cells involved in allograft rejection?

  1983cited by this paper
• Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

  1982cited by this paper
• Rat myocardial cells in vitro: Mitosis and differentiated properties

  1972cited by this paper

• No citing papers are available for this paper.